Explore the latest in atrial fibrillation, including advances in treatment and stroke prevention, recent guidelines, and long-term outcomes.
This secondary analysis of a randomized clinical trial examines whether adding posterior wall isolation to pulmonary vein isolation improves outcomes in patients with heart failure (HF) with reduced ejection fraction and atrial fibrillation (AF).
This cohort study compares rates of hypertension among nonhypertensive patients with atrial fibrillation using JNC 8 vs ACC/AHA thresholds.
This cohort study investigates the incidence, prevalence, trends in disease burden, and associated mortality and comorbid conditions of cardiovascular disease among American Indian and Alaska Native Medicare beneficiaries from January 1, 2015, to December 30, 2019.
This diagnostic study evaluates the optimal cutoff for phosphatidylethanol for heavy alcohol consumption in a study of middle-age and older adults.
This randomized clinical trial evaluates the prevalence of psychological distress in participants referred for atrial fibrillation treatment.
This cohort study estimates age-dependent risks for cardiovascular events with the amyloidogenic pV142I variant.
This randomized clinical trial compares outcome data from circumferential pulmonary vein isolation treatment in patients aged 65 to 80 years with paroxysmal atrial fibrillation to explore the incremental benefit of additional substrate ablation in patients low-voltage areas.
This study examines associations between an accelerometer-derived “weekend warrior” pattern (ie, most moderate to vigorous physical activity achieved over 1-2 days) vs similar physical activity spread more evenly and the risk of incident cardiovascular events.
This cohort study examines whether underdosing of direct oral anticoagulants not recommended by the Food and Drug Administration is associated with longitudinal adherence to anticoagulation treatment among patients with nonvalvular atrial fibrillation (NVAF).
This study investigates whether preterm birth, small for gestational age, or large for gestational age are associated with increased risks of atrial fibrillation later in life.
This case report discusses a diagnosis of scimitar syndrome in a woman aged 79 years who presented with worsening dyspnea on exertion and new-onset atrial fibrillation.
This randomized clinical trial evaluates the superiority of an augmented double wide-area circumferential ablation vs a standard single wide-area circumferential ablation in preventing recurrent atrial arrhythmias in patients with paroxysmal atrial fibrillation.
This cohort study investigates time trends in patient characteristics, anticoagulation treatment, and prognosis of patients with incident nonvalvular atrial fibrillation in the Netherlands.
This cohort study investigates the association of dexmedetomidine use with risk of new-onset atrial fibrillation among patients who are critically ill.
This cohort study assesses the perceptions of patients with atrial fibrillation and their physicians about the benefits and risks of anticoagulation.
This ad hoc analysis of a randomized clinical trial assesses bradyarrhythmia prevalence and prognostic significance in persons screened for atrial fibrillation using implantable loop recorder compared with unscreened persons.
This cohort study investigates whether positive longitudinal left atrial strain and positive longitudinal left atrial strain rate are associated with new-onset ischemic stroke among older adults.
This comparative effectiveness study uses data from 3 US claims databases to assess the comparative safety and effectiveness of specific oral anticoagulant therapies by dementia status among older patients with atrial fibrillation.
Customize your JAMA Network experience by selecting one or more topics from the list below.